21 Oct 2016
4SC AG: Biotech Company from Munich
Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biotech company with a strong focus on clinical development.
We discover and develop targeted small molecule drugs with an epigenetic mode of action for the treatment of cancer in indications with a high unmet medical need and major economic potential.
We wish to offer affected patients treatment options that are more effective and better tolerated to provide a better quality of life.
Our product pipeline comprises promising drug programs at various stages of clinical development, as well as early-stage research projects. We are focusing on fields of research with an especially promising future – such as epigenetics, cancer stem cells, cancer immunotherapy and other, important cell communication patterns that contribute to the development and persistence of cancer.